MiNK Therapeutics, Inc. (NASDAQ:INKT) Q3 2024 Earnings Call Transcript November 14, 2024
Emily Bodnar – H.C. Wainwright:
Operator: Thank you for standing by. I would like to welcome everyone to the MiNK Therapeutics Third Quarter 2024 Financial Results. I would now like to turn the call over to Alexa Buffa from MiNK’s Corporate Communications. Please go ahead.
Alexa Buffa : Thank you, operator, and thank you all for joining us today. Today’s call is being webcast and will be available on our...
